Command Palette

Search for a command to run...

Tier IIIResin · 5-LOX inhibitor142 trials

Boswellia serrata — The 5-LOX Inhibitor

Boswellia serrata, also known as Indian frankincense, is a botanical resin with potent anti-inflammatory properties. In the context of longevity, it targets 'inflammaging' by suppressing pro-inflammatory pathways, offering significant protection against age-related joint degradation and systemic inflammation.

Mechanism of Action

The primary active compounds in Boswellia serrata are boswellic acids, with AKBA (3-O-acetyl-11-keto-beta-boswellic acid) being the most potent. AKBA directly binds to and inhibits 5-lipoxygenase (5-LOX), preventing the synthesis of pro-inflammatory leukotrienes. Additionally, boswellic acids inhibit the activation of NF-κB, downregulating the expression of cytokines such as TNF-alpha, IL-1beta, and IL-6. This dual action mitigates chronic low-grade inflammation and reduces the enzymatic degradation of cartilage and connective tissues.

Human Trial Evidence

Boswellia serrata is well-supported by human clinical trials, particularly for osteoarthritis. Multiple randomized, double-blind, placebo-controlled trials have demonstrated that standardized Boswellia extracts significantly reduce joint pain, decrease stiffness, and improve physical function within weeks of supplementation. Evidence also supports its efficacy in managing inflammatory bowel disease and asthma, though specific human longevity trials are lacking.

Dosing Protocol

Typical dosing ranges from 300 to 500 mg of standardized extract (often containing 60-65% boswellic acids) taken two to three times daily. Patented extracts enriched for AKBA (such as 5-Loxin or ApresFlex) are typically dosed lower, at 100 to 250 mg per day. It is best taken with a fat-containing meal to enhance absorption.

Safety & Contraindications

Boswellia serrata is generally well-tolerated with a strong safety profile. The most common adverse effects are mild gastrointestinal disturbances, including nausea, acid reflux, and diarrhea. It may interact with NSAIDs, anticoagulants, and certain cytochrome P450 substrates. It should be avoided during pregnancy due to potential emmenagogue effects.

Key Papers

Quick Stats
Evidence TierTier III
Clinical Trials142
Typical Dose500 mg
Est. Cost/Day$0.20
Purity98.0%
Synergistic Compounds
CurcuminFish OilGingerGlucosamine
Medical disclaimer: This page is for informational purposes only. Consult a qualified healthcare provider before starting any supplement regimen. Vitaei does not provide medical advice.